1. Home
  2. PRME vs CDRE Comparison

PRME vs CDRE Comparison

Compare PRME & CDRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRME
  • CDRE
  • Stock Information
  • Founded
  • PRME 2019
  • CDRE 2012
  • Country
  • PRME United States
  • CDRE United States
  • Employees
  • PRME N/A
  • CDRE N/A
  • Industry
  • PRME Medicinal Chemicals and Botanical Products
  • CDRE Industrial Specialties
  • Sector
  • PRME Health Care
  • CDRE Health Care
  • Exchange
  • PRME Nasdaq
  • CDRE Nasdaq
  • Market Cap
  • PRME 191.7M
  • CDRE 1.3B
  • IPO Year
  • PRME 2022
  • CDRE 2021
  • Fundamental
  • Price
  • PRME $4.27
  • CDRE $32.69
  • Analyst Decision
  • PRME Buy
  • CDRE Buy
  • Analyst Count
  • PRME 6
  • CDRE 2
  • Target Price
  • PRME $9.38
  • CDRE $37.50
  • AVG Volume (30 Days)
  • PRME 5.0M
  • CDRE 279.1K
  • Earning Date
  • PRME 08-04-2025
  • CDRE 08-08-2025
  • Dividend Yield
  • PRME N/A
  • CDRE 1.17%
  • EPS Growth
  • PRME N/A
  • CDRE N/A
  • EPS
  • PRME N/A
  • CDRE 0.95
  • Revenue
  • PRME $3,846,000.00
  • CDRE $559,807,000.00
  • Revenue This Year
  • PRME $104.12
  • CDRE $13.31
  • Revenue Next Year
  • PRME $108.24
  • CDRE $7.96
  • P/E Ratio
  • PRME N/A
  • CDRE $34.36
  • Revenue Growth
  • PRME 550.76
  • CDRE 10.06
  • 52 Week Low
  • PRME $1.11
  • CDRE $27.07
  • 52 Week High
  • PRME $6.75
  • CDRE $40.28
  • Technical
  • Relative Strength Index (RSI)
  • PRME 80.29
  • CDRE 47.89
  • Support Level
  • PRME $2.28
  • CDRE $31.64
  • Resistance Level
  • PRME $4.83
  • CDRE $32.99
  • Average True Range (ATR)
  • PRME 0.46
  • CDRE 0.71
  • MACD
  • PRME 0.21
  • CDRE 0.01
  • Stochastic Oscillator
  • PRME 84.52
  • CDRE 72.95

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

About CDRE Cadre Holdings Inc.

Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The Company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments: Products and Distribution.

Share on Social Networks: